Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Direct-to-Consumer, Open-label Study Investigating the Tolerability of BG-OS in Healthy Individuals in a Home Setting

NCT06739941 is registered in ClinicalTrials.gov with One Bio Inc. as lead sponsor.

NCT NCT06739941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06739941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Direct-to-Consumer, Open-label Study Investigating the Tolerability of BG-OS in Healthy Individuals in a Home Setting
Lead sponsor
One Bio Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2025
Completion date
April 25, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

digestive health, metabolic health